🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Arnulf Stenzl Laurence Albiges 💙alison birtle Alberto Briganti Maria De Santis prof. Stefano Fanti Valérie Fonteyne Juan Gómez Rivas Robert Huddart💙 Axel S. Merseburger Andrea Necchi Christoph_Oing Jan Oldenburg Piet Ost Maria J. Ribal Morgan Roupret Thomas Zilli

At #BLADDR23: great talk by Paul Sargos on role of adjuvant Radiotherapy in R1 MIBC: what are we doing differentially nowadays? 1) we have better criteria for patiënt selection 2) we have international guidelines on target delineation 3) we apply modern RT techniques

Looking forward to present at #GU24: Treatment intensification: what to do for patients with early castration-resistant PCa who received doublet or triplet therapy. Is there a place for Stereotactic Radiotherapy?

Is there a role for stereotactic radiotherapy in selected patients with metastatic castrate-resistant #ProstateCancer? Check out this presentation by Valérie Fonteyne UGent. #GU24 written coverage by Rashid K. Sayyid University of Toronto on UroToday > bit.ly/3Sydip9 ASCO

3-year toxicity after moderate hypofractionated radiotherapy: a Belgian phase 3 trial adding to the evidence that moderate hypofractionated radiotherapy is feasible in unselected prostate cancer patients. Teamwork UZ Gent universiteit Gent lnkd.in/eMK4k3BJ

steven joniau Maarten Albersen Shahrokh F. Shariat Tom Powles Thierry Roumeguere Karel Decaestecker Valérie Fonteyne Loïc Baekelandt Gert De Meerleer tombal Lorenzo TOSCO Kato Rans Eduard Roussel European Society of Residents in Urology BVU Société Belge d'Urologie

#ESTRO24 Flor Verghote adding to the emerging role of adjuvant RT for bladder cancer Intriguing that only 3/14 pts with positive surgical margins had pelvic failures #radonc

Interested in reading the protocol? pubmed.ncbi.nlm.nih.gov/37208232/ Interested in the early results? Coming soon at a conference near you! #BladderCancerAwarenessMonth 🧡 Fight Bladder Cancer Bladder Cancer Advocacy Network Ashish M. Kamat, MD, MBBS Shilpa Gupta Neeraj Agarwal, MD, FASCO Valérie Fonteyne

We learned a lot about muscle-invasive bladder cancer this past week. Together, these studies suggest that a strategy worth exploring is to further de-intensify surgical lymph node management to reduce surgery-related mortality, while using adjuvant radiation to treat nodes in

A great Pleasure to Present our paper on Management of patients with Advanced #ProstateCancer : A Report from #APCCC24 LINK TO ARTICLE👇👇👇👇👇👇👇👇 sciencedirect.com/science/articl… The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) highlights significant advances in

Enrique Grande UroToday.com Omar Mian Fred Hutch Cancer Center Rashid K. Sayyid For sure underutilized. ⚡ Safe and efficient with many prospective data available.. And many to come! Vedang Murthy Jonathan Khalifa 🎗️ Valérie Fonteyne Brian C. Baumann John Christodouleas GETUG

Recap of a first excellent day of the Belgian Urology Conference in Spa! Kudos to AFrançoise Spinoit for the great organization! And endlessly proud of our team 💪🏽 UZ Gent UGent Geneeskunde & Gezondheidswetenschappen François HERVÉ Charles Van Praet marjan waterloos Valérie Fonteyne #BAU24

Does SBRT for oligorecurrent #prostatecancer improve overall survival as compared to SOC? WOLVERINE reporting on STOMP, ORIOLE, EXTEND and ARTO. Presented by Chad Tang, MD at #GU25.

Updated results by Flor Verghote of the Belgian trial on Adjuvant Radiotherapy for MIBC! Awaiting the results of the trials by Paul Sargos and Vedang Murthy UGent UZ Gent Camille Berquin Charles Van Praet John Christodouleas Brian C. Baumann sciencedirect.com/science/articl…

I usually don’t post political views but now…. youtu.be/JhkZMxgPxXU

High-risk biochemical recurrence with positive PSMA PET: Radiotherapy still matters. Presentation by Valérie Fonteyne UZ Gent. #EAU25 written coverage by Rashid K. Sayyid USC > bit.ly/4l33Sy7 European Association of Urology (EAU)

Honoured to had the opportunity to discuss the place of Adjuvant Radiotherapy for bladder Cancer and presenting the results of the Belgian trial supporting this approach! Motivated to proceed with our ongoing EFFORT trial! Flor Verghote Camille Berquin De Maeseneer Daan UZ Gent UGent